newsfilter
← Latest News
Business Wire·

CEL-SCI Reports Fiscal Third Quarter 2025 Financial Results

CEL-SCI to sign partnership agreement in Saudi Arabia—Potential for patient access and reimbursement/sale of Multikine in Saudi Arabia within approximately 60 days following filing for Breakthrough Medicine